3Strandberg TE,Pitkala K,Kulp S,et al.Use of cardiovascular drugs by home-dwelling coronary patients aged 75 years and older.A population-based cross-sectional survey in Helsinki,Finland[J].Eur J Clin Pharmacol,2001,57 (6-7):513-516. 被引量：1
4Psaty BM,Lee M,Savage PJ,et al.Assessing the use of medications in the elderly methods and initical experience in the cardiovascular health study.The cardiovascular health study collaborative research group[J].J Clin Epidemiol,1992,45(6):683-692. 被引量：1
5Kulkarni SP,Alexander KP,Lytle B,et al.Long-term adherence with cardiova-scular drug regimens[J].Am Heart J,2006,151(1):185-191. 被引量：1
6Soumerai SB,McLaughlin TJ,Spiegelman D,et al.Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction[J].JAMA,1997,277(2):115-121. 被引量：1
7Lappe JM,Muhlestein JB,Lappe DL,et al.Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program[J].Ann Intern Med,2004,141(6):446-453. 被引量：1
8Bi Y,Gao R,Pelal A,et al.Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization:Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study[J].Am Heart J,2009,157:509-516. 被引量：1
9Strandberg TE,Pitkala K,Kulp S,et al.Use of cardiovascular drugs by home-dwelling coronary patients aged 75 years and older.A population-based cross-sectional survey in Helsinki,Finland[J].Eur J Clin Pharmacol,2001,57(6～7):513～516. 被引量：1
10Psaty BM,Lee M,Savage PJ,et al.Assessing the use of medications in the elderly methods and initical experience in the Cardiovascular Health Study.The Cardiovascular Health Study Collaborative Research Group[J].J Clin Epidemiol,1992,45 (6):683～692. 被引量：1
